From Biomarkers to Breakthroughs: Advancing Alzheimer’s Diagnostics and Therapeutics, Including Inflammation and GLP-1 Pathways

Alzheimer’s disease remains one of the most urgent and complex challenges in medicine. This panel will explore the latest scientific advances shaping the future of Alzheimer’s diagnostics and therapeutics, from the identification of novel biomarkers to emerging treatment strategies. Experts will discuss breakthroughs in early detection, the evolving role of neuroinflammation, and the therapeutic potential of targeting GLP-1 receptor pathways. Focusing on translating cutting-edge research into clinical progress, this session will provide an encompassing review of where the field stands today and what lies ahead in the development of therapeutic solutions for Alzheimer’s disease.